New Strategy Boosts Microenvironment to Promote Antitumor Immunity in GI Metastases
August 1st 2017Despite the promise of immunotherapy for treating patients with advanced cancers, the success of using such therapies for progressive gastrointestinal malignancies such as colorectal liver metastases (CRLM) has been limited so far.